Shares of ANGLE plc (LON:AGL – Get Free Report) crossed above its fifty day moving average during trading on Friday. The stock has a fifty day moving average of GBX 2.35 and traded as high as GBX 2.90. ANGLE shares last traded at GBX 2.35, with a volume of 1,682,496 shares.
ANGLE Price Performance
The stock has a market capitalization of £7.58 million, a PE ratio of -0.49 and a beta of 0.22. The company has a debt-to-equity ratio of 25.25, a current ratio of 2.76 and a quick ratio of 6.17. The company has a 50-day moving average of GBX 2.35 and a two-hundred day moving average of GBX 2.35.
About ANGLE
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.
Recommended Stories
- Five stocks we like better than ANGLE
- Home Depot and Lowe’s Hit 52-Week Lows—But Analysts Aren’t Giving Up
- Utilities Are Bouncing Back—These 2 Giants Could Signal the Next Big Sector Rally
- Q3 Earnings Could Blow Past Consensus—Be Ready for What Comes Next
- Why Wall Street Expects Even More From SanDisk After Its 575% Rally
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.
